FDA Inspection
Baxter Healthcare CorporationBaxter Healthcare Corporation – FDA Inspection, Nov 25, 2025
Record Details
This FDA Inspection record concerns Baxter Healthcare Corporation, with an inspection on November 25, 2025, issued by the Chicago District Office, covering biologics.
View Company Profile
ID · 46a0ecf1-f482-4d18-a1db-7208eb366b5d
Inspection Facts
- Inspection number
- 1293034
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
FDA Citations
5- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.194(a)(1)Sample identification and other information
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.25(a)Training , Education , Experience overall
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Baxter Healthcare Corporation
19| Date | Classification | Office | Project area |
|---|---|---|---|
| April 2, 2026 | Not classified | Chicago District Office | Drug Quality Assurance |
| August 1, 2024 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 18, 2023 | VAI | Center for Devices and Radiological Health | Compliance: Devices |
| September 26, 2018 | Not classified | Chicago District Office | |
| July 14, 2017 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Baxter Healthcare Corporation
- FDA Inspection 1311078 - 2026-04-02
- FDA Inspection 1243362 - 2024-08-01
- FDA Inspection 1215194 - 2023-08-18
- FDA Inspection 1068273 - 2018-09-26
- FDA Inspection 1024072 - 2017-07-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.